正帆科技 (688596)

Shanghai Gentech Co., Ltd.

KSH

Tags

Third-Generation SemiconductorsSSE 380 IndexSpecial Purpose Equipment ManufacturingSpecialized-Sophisticated-Distinctive-Innovative EnterprisesEnergy StorageSemiconductorsSynthetic BiologyContains Convertible BondsMemory ChipsIndustrial GasesPlanned Reduction of HoldingsHydrogen EnergyElectronicsSTAR Market 200 IndexSTAR Market High-End Equipment IndexChipsMargin Trading and Securities LendingHigh-End EquipmentHigh Margin Positions

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 29292.40
  • Circulating A-Shares(W): 29292.40
  • Earnings Per Share(RMB): 0.2500
  • Net Assets Per Share(RMB): 12.2178
  • Operating Revenue(W RMB): 329200.81
  • Total Profit(W RMB): 3639.13
  • **Net Profit Attributable to Parent(W RMB) **: 7130.26
  • Net Profit Growth Rate(%): -78.50
  • Weighted Return on Equity(%): 1.9700
  • Operating Cash Flow Per Share(RMB): -0.7540
  • Undistributed Profit Per Share(RMB): 4.8480
  • Capital Reserve Per Share(RMB): 6.2130

2. Main Business

The main business covers:

  • Design, production, installation and supporting services for gas chemical supply systems
  • Production and sales of high-purity specialty gases
  • Design and construction of clean room supporting systems

3. Company Basic Information

  • Company Name: Shanghai Gentech Industries Co., Ltd.
  • Listing Date: 2020-08-20
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No. 55 Chunyong Road, Minhang District, Shanghai
  • Website: https://www.gentechindustries.com
  • Company Profile: On May 25, 2015, Gentech Limited held a board meeting and resolved to convert Gentech Limited's net assets of RMB 189,067,484.74, audited by Lixin CPAs (Audit Report No. [2015]114287), as of April 30, 2015, into company shares at a ratio of 1:0.578471746, resulting in 109,370,198 shares with a par value of RMB 1 per share and a total share capital of RMB 109,370,198. The balance of RMB 79,697,286.74 was recorded as capital reserve. The aforementioned net assets were assessed by Yinxin Assessment (Assessment Report No. Yinzipingbao [2015] Hu No. 0431). As of April 30, 2015, the assessed fair value of the net assets of Gentech Limited's shareholders' equity was RMB 242.8125 million, representing an increase of RMB 34.2245 million compared to the audited net asset value, an appreciation rate of 16.41%. The assessed value exceeded the audited net asset amount. On June 5, 2015, all shareholders of Gentech Limited signed the "Sponsor Agreement of Shanghai Gentech Industries Co., Ltd." and the "Articles of Association of Shanghai Gentech Industries Co., Ltd.", confirming the conversion of Gentech Limited into a joint stock limited company. On June 29, 2015, the Shanghai Municipal Commission of Commerce issued the approval document "Hushangwaizi Pi [2015] No. 2316", approving the company's conversion from a joint venture enterprise to a joint stock limited company named Shanghai Gentech Industries Co., Ltd., and approving the sponsor agreement and articles of association signed by the sponsors of Gentech Limited on June 5, 2015. On June 30, 2015, the Shanghai Municipal People's Government issued the "Approval Certificate for Enterprises with Investment from Taiwan, Hong Kong, Macao, and Overseas Chinese" (No. Shangwaizi Hu Gufen Zi [2011]2417) to Gentech. On June 30, 2015, Lixin CPAs issued the Capital Verification Report (No. [2015]114674) verifying the aforementioned conversion. On the same day, the sponsors of Gentech held the founding meeting. On July 8, 2015, Gentech Limited completed the corresponding industrial and commercial registration changes for the overall conversion and obtained the renewed business license for the joint stock limited company (Registration No.: 310112000926104) from the Shanghai Administration for Industry and Commerce. On August 24, 2019, Rongcheng CPAs issued the "Capital Verification Review Report" (Huiyanzi [2019] No. 7336), reviewing the Capital Verification Report (No. [2015]114674) issued by Lixin CPAs for the overall conversion of Gentech Limited into a joint stock limited company in 2015.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Fengfan Holding Co., Ltd. General Legal Person 5078.93 17.34
2 Orient AI Theme Mixed Securities Investment Fund Class A Fund 921.38 3.15
3 Shanghai Gentech Industries Co., Ltd. - Phase II Employee Stock Ownership Plan Asset Management Plan 610.46 2.08
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 264.00 0.90
5 Hui'an Hongyang Three-Year Holding Mixed Securities Investment Fund Fund 169.83 0.58
6 Hui'an Balanced Preferred Mixed Securities Investment Fund Fund 132.03 0.45
7 CITIC Securities Industry Rotation Mixed Securities Investment Fund Class A Fund 118.14 0.40
8 GF Theme Leading Flexible Allocation Mixed Securities Investment Fund Class A Fund 100.00 0.34
9 CITIC Securities Value Selection Mixed Securities Investment Fund Class A Fund 69.93 0.24
10 Hui'an Runyang Three-Year Holding Mixed Securities Investment Fund Class A Fund 67.54 0.23

5. Concept Sectors

  • Convertible Bonds
  • High-End Equipment
  • Chips
  • Hydrogen Energy
  • Energy Storage
  • Industrial Gases
  • Third Generation Semiconductors
  • Memory Chips
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Recent New Lows
  • Proposed Reduction
  • High Margin Financing
  • Specialized, Refined, Unique, New (SRUN)
  • SSE 380
  • STAR Market High-End Equipment
  • STAR Market 200

Remarks

  • Data update date: 2025-11-01
  • Data source: Public Market Information